225 related articles for article (PubMed ID: 36095001)
1. Vaccine-linked chemotherapy with a low dose of benznidazole plus a bivalent recombinant protein vaccine prevents the development of cardiac fibrosis caused by Trypanosoma cruzi in chronically-infected BALB/c mice.
Dzul-Huchim VM; Ramirez-Sierra MJ; Martinez-Vega PP; Rosado-Vallado ME; Arana-Argaez VE; Ortega-Lopez J; Gusovsky F; Dumonteil E; Cruz-Chan JV; Hotez P; Bottazzi ME; Villanueva-Lizama LE
PLoS Negl Trop Dis; 2022 Sep; 16(9):e0010258. PubMed ID: 36095001
[TBL] [Abstract][Full Text] [Related]
2. The impact of vaccine-linked chemotherapy on liver health in a mouse model of chronic Trypanosoma cruzi infection.
Nguyen DM; Poveda C; Pollet J; Gusovsky F; Bottazzi ME; Hotez PJ; Jones KM
PLoS Negl Trop Dis; 2023 Nov; 17(11):e0011519. PubMed ID: 37988389
[TBL] [Abstract][Full Text] [Related]
3. Vaccine-linked chemotherapy induces IL-17 production and reduces cardiac pathology during acute Trypanosoma cruzi infection.
Cruz-Chan JV; Villanueva-Lizama LE; Versteeg L; Damania A; Villar MJ; González-López C; Keegan B; Pollet J; Gusovsky F; Hotez PJ; Bottazzi ME; Jones KM
Sci Rep; 2021 Feb; 11(1):3222. PubMed ID: 33547365
[TBL] [Abstract][Full Text] [Related]
4. Cysteine mutagenesis improves the production without abrogating antigenicity of a recombinant protein vaccine candidate for human chagas disease.
Seid CA; Jones KM; Pollet J; Keegan B; Hudspeth E; Hammond M; Wei J; McAtee CP; Versteeg L; Gutierrez A; Liu Z; Zhan B; Respress JL; Strych U; Bottazzi ME; Hotez PJ
Hum Vaccin Immunother; 2017 Mar; 13(3):621-633. PubMed ID: 27737611
[TBL] [Abstract][Full Text] [Related]
5. Production of recombinant TSA-1 and evaluation of its potential for the immuno-therapeutic control of Trypanosoma cruzi infection in mice.
de la Cruz JJ; Villanueva-Lizama L; Dzul-Huchim V; Ramírez-Sierra MJ; Martinez-Vega P; Rosado-Vallado M; Ortega-Lopez J; Flores-Pucheta CI; Gillespie P; Zhan B; Bottazzi ME; Hotez PJ; Dumonteil E
Hum Vaccin Immunother; 2019; 15(1):210-219. PubMed ID: 30192702
[TBL] [Abstract][Full Text] [Related]
6. A therapeutic vaccine prototype induces protective immunity and reduces cardiac fibrosis in a mouse model of chronic Trypanosoma cruzi infection.
Barry MA; Versteeg L; Wang Q; Pollet J; Zhan B; Gusovsky F; Bottazzi ME; Hotez PJ; Jones KM
PLoS Negl Trop Dis; 2019 May; 13(5):e0007413. PubMed ID: 31145733
[TBL] [Abstract][Full Text] [Related]
7. Safety and immunogenicity of a recombinant vaccine against Trypanosoma cruzi in Rhesus macaques.
Dumonteil E; Herrera C; Tu W; Goff K; Fahlberg M; Haupt E; Kaur A; Marx PA; Ortega-Lopez J; Hotez PJ; Bottazzi ME
Vaccine; 2020 Jun; 38(29):4584-4591. PubMed ID: 32417142
[TBL] [Abstract][Full Text] [Related]
8. Vaccine-Linked Chemotherapy Improves Benznidazole Efficacy for Acute Chagas Disease.
Jones K; Versteeg L; Damania A; Keegan B; Kendricks A; Pollet J; Cruz-Chan JV; Gusovsky F; Hotez PJ; Bottazzi ME
Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29311242
[TBL] [Abstract][Full Text] [Related]
9. A therapeutic nanoparticle vaccine against Trypanosoma cruzi in a BALB/c mouse model of Chagas disease.
Barry MA; Wang Q; Jones KM; Heffernan MJ; Buhaya MH; Beaumier CM; Keegan BP; Zhan B; Dumonteil E; Bottazzi ME; Hotez PJ
Hum Vaccin Immunother; 2016 Apr; 12(4):976-87. PubMed ID: 26890466
[TBL] [Abstract][Full Text] [Related]
10. Expression, purification, immunogenicity, and protective efficacy of a recombinant Tc24 antigen as a vaccine against Trypanosoma cruzi infection in mice.
Martinez-Campos V; Martinez-Vega P; Ramirez-Sierra MJ; Rosado-Vallado M; Seid CA; Hudspeth EM; Wei J; Liu Z; Kwityn C; Hammond M; Ortega-López J; Zhan B; Hotez PJ; Bottazzi ME; Dumonteil E
Vaccine; 2015 Aug; 33(36):4505-12. PubMed ID: 26192358
[TBL] [Abstract][Full Text] [Related]
11. Location and expression kinetics of Tc24 in different life stages of Trypanosoma cruzi.
Versteeg L; Adhikari R; Poveda C; Villar-Mondragon MJ; Jones KM; Hotez PJ; Bottazzi ME; Tijhaar E; Pollet J
PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009689. PubMed ID: 34478444
[TBL] [Abstract][Full Text] [Related]
12. Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice: role of CD4+ and CD8+ T cells.
Limon-Flores AY; Cervera-Cetina R; Tzec-Arjona JL; Ek-Macias L; Sánchez-Burgos G; Ramirez-Sierra MJ; Cruz-Chan JV; VanWynsberghe NR; Dumonteil E
Vaccine; 2010 Oct; 28(46):7414-9. PubMed ID: 20850536
[TBL] [Abstract][Full Text] [Related]
13. TLR4 agonist protects against Trypanosoma cruzi acute lethal infection by decreasing cardiac parasite burdens.
Villanueva-Lizama LE; Cruz-Chan JV; Versteeg L; Teh-Poot CF; Hoffman K; Kendricks A; Keegan B; Pollet J; Gusovsky F; Hotez PJ; Bottazzi ME; Jones KM
Parasite Immunol; 2020 Oct; 42(10):e12769. PubMed ID: 32592180
[TBL] [Abstract][Full Text] [Related]
14. Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease.
Rial MS; Scalise ML; Arrúa EC; Esteva MI; Salomon CJ; Fichera LE
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006119. PubMed ID: 29267280
[TBL] [Abstract][Full Text] [Related]
15. The impact of vaccine-linked chemotherapy on liver health in a mouse model of chronic
Nguyen DM; Poveda C; Pollet J; Gusovsky F; Bottazzi ME; Hotez PJ; Jones KM
bioRxiv; 2023 Jul; ():. PubMed ID: 37503013
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in mice.
Dumonteil E; Escobedo-Ortegon J; Reyes-Rodriguez N; Arjona-Torres A; Ramirez-Sierra MJ
Infect Immun; 2004 Jan; 72(1):46-53. PubMed ID: 14688079
[TBL] [Abstract][Full Text] [Related]
17. A human type 5 adenovirus-based Trypanosoma cruzi therapeutic vaccine re-programs immune response and reverses chronic cardiomyopathy.
Pereira IR; Vilar-Pereira G; Marques V; da Silva AA; Caetano B; Moreira OC; Machado AV; Bruna-Romero O; Rodrigues MM; Gazzinelli RT; Lannes-Vieira J
PLoS Pathog; 2015 Jan; 11(1):e1004594. PubMed ID: 25617628
[TBL] [Abstract][Full Text] [Related]
18. Preventive and therapeutic DNA vaccination partially protect dogs against an infectious challenge with Trypanosoma cruzi.
Quijano-Hernández IA; Castro-Barcena A; Vázquez-Chagoyán JC; Bolio-González ME; Ortega-López J; Dumonteil E
Vaccine; 2013 Apr; 31(18):2246-52. PubMed ID: 23499599
[TBL] [Abstract][Full Text] [Related]
19. Trypanosoma cruzi vaccine candidate antigens Tc24 and TSA-1 recall memory immune response associated with HLA-A and -B supertypes in Chagasic chronic patients from Mexico.
Villanueva-Lizama LE; Cruz-Chan JV; Aguilar-Cetina ADC; Herrera-Sanchez LF; Rodriguez-Perez JM; Rosado-Vallado ME; Ramirez-Sierra MJ; Ortega-Lopez J; Jones K; Hotez P; Bottazzi ME; Dumonteil E
PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006240. PubMed ID: 29377898
[TBL] [Abstract][Full Text] [Related]
20. Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming.
Hoft DF; Eickhoff CS; Giddings OK; Vasconcelos JR; Rodrigues MM
J Immunol; 2007 Nov; 179(10):6889-900. PubMed ID: 17982080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
